{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-012316","form_type":"8-K","ticker":"CURX","cik":"0002025942","company_name":"Curanex Pharmaceuticals Inc","filed_at":"2025-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.851171+00:00","generated_at":"2026-05-17T10:04:35.828306+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Curanex Pharmaceuticals prices IPO of 3.75M shares at $4.00/share, gross $15M","bullets":["Gross proceeds $15M from 3.75M shares at $4.00/share; net proceeds ~$12.1M after underwriting discounts and expenses.","Shares expected to begin trading on Nasdaq (CURX) on Aug 26, 2025; close expected Aug 27, 2025.","Underwriters have 45-day option to purchase up to 562,500 additional shares to cover over-allotments.","Proceeds to fund Phyto-N (ulcerative colitis) development, GLP toxicology/pharmacokinetic studies, IND submission, and working capital.","Lead underwriter: Dominari Securities; co-underwriters: Pacific Century Securities and Revere Securities."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-012316","json":"https://secwatch.observer/filing/0001493152-25-012316.json","markdown":"https://secwatch.observer/filing/0001493152-25-012316.md","text":"https://secwatch.observer/filing/0001493152-25-012316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2025942/000149315225012316/0001493152-25-012316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2025942/000149315225012316/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:04:35.828306+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}